Form 4: Precipio Director Acquires Stock Options in Recent Transaction

Director David Seth Cohen acquired 1,000 stock options in Precipio, Inc., according to a recent SEC filing.

Summary

• David Seth Cohen, a director at Precipio, Inc., acquired 1,000 stock options on January 14, 2025.
• The options have an exercise price of $6.06 per share.
• The options vest in twelve equal monthly installments starting one month after the issuance date.
• The options expire on January 14, 2035.
• The options were granted as part of the company's Equity Incentive Plan in consideration for Cohen's service as a director.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction of stock options to a director, which is generally positive for aligning interests but not a major event.

Positives

• The grant of stock options to a director aligns their interests with those of the shareholders.
• The vesting schedule encourages the director's continued service to the company.

Industry Context

This is a standard practice for companies to incentivize directors and align their interests with shareholders through equity compensation.

Comparison to Industry Standards

• Granting stock options to directors is a common practice across various industries, including biotechnology and healthcare, where Precipio operates.
• The vesting schedule of 12 months is also typical for such grants, aligning with industry norms for incentivizing long-term commitment.
• Companies like Exact Sciences and Guardant Health also use stock options as part of their compensation packages for directors and executives.

Stakeholder Impact

• The stock option grant may have a minor positive impact on shareholder sentiment as it aligns director interests with company performance.

Key Dates

Keywords

stock options, Precipio, director, equity incentive plan, SEC Form 4, insider trading